MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, RAPH has $53K in assets.

Balance Sheets Overview

Current Ratio
3.43%
Quick Ratio
3.43%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Fixed asset, net
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid-in capital
    • Payable to related party
    • Others

Balance Sheets
2025-12-31
Cash and cash equivalents
45
Other current assets
6
Total current assets
51
Fixed asset, net
2
Total assets
53
Other accounts payable and accrued expenses
506
Short-term credit from a related party
34
Payable to related party
946
Total current liabilities
1,486
Common stock, 0.01 par value authorized 21,020,560 shares issued and outstanding 20,176,418 and 18,701,418 as of december 31, 2025 and december 31, 2024, respectively
202
Additional paid-in capital
8,533
Accumulated deficit
-10,168
Total stockholders equity (deficit)
-1,433
Total liabilities and stockholders equity
53
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$45K Other current assets$6K Total current assets$51K Fixed asset, net$2K Total assets$53K Accumulated deficit-$10,168K Total liabilities andstockholders equity$53K Total stockholdersequity (deficit)-$1,433K Additional paid-in capital$8,533K Common stock, 0.01 parvalue authorized...$202K Total currentliabilities$1,486K Payable to related party$946K Other accountspayable and accrued...$506K Short-term credit from arelated party$34K

Raphael Pharmaceutical Inc. (RAPH)

Raphael Pharmaceutical Inc. (RAPH)